期刊文献+

重组人白细胞介素17的原核表达、纯化及鉴定 被引量:2

Prokaryotic Expression, Purification and Characterization of Recombinant Human Interleukin-17
暂未订购
导出
摘要 目的:优化重组人白细胞介素17的原核表达条件,选择不同的路线进行分离纯化.方法:利用SDS-PAGE方法分析比较重组人白细胞介素17在不同培养基、不同诱导时间的表达量,选择最适条件,大量扩增后,分离出包涵体,分别采用盐酸胍溶解法和SDS溶解法两条纯化路线进行进一步的分离和纯化,并对所纯化产物进行常规分析鉴定.结果:采用上述两种不同的溶解包涵体方法,通过后续复性及纯化,均可得到高纯度具有生物学活性的重组IL-17.采用SDS溶解法具有较高的得率,采用盐酸胍溶解法纯化得率较低,得产物的生物学活性较高.结论:通过表达及纯化,得到了大量高纯度具有活性的rhIL-17,为进一步研究IL-17的体内外生物学效应打下了基础. Objective: To select suitable conditions for prokaryotic expression and purification of rhIL-17. Methods: rhIL-17 was expressed in E. coli host under heat induction. After compared among the expression amounts in different media under different heat induction time, the most suitable conditions was selected. The target protein was present in the form of inclusion body. The precipitate of inclusion was obtained and purified after 6M guanidine solublization or 2% SDS solublization. Results: Either protocol could yield rhIL-17 with high purity and stable activity. The SDS solublization mehthod gives rise to much more higher productivity than the guanidine solublization method. Conclusion: rhIL-17 were expression in E. coli system and purified to homogenicity by SDS solublization methods with high productivity.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 1999年第4期273-276,共4页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金重点项目(39730420) 国家杰出青年科学基金(39825123)资助
关键词 原核表达 纯化 鉴定 IL-17 γhIL-17 recombinant human interlukin 17 prokaryotic expression renaturation purification characterization
  • 相关文献

参考文献1

  • 1黄欣 赵忠良 等.白细胞介素17(IL-17)的克隆在大肠杆菌中的表达[J].中国肿瘤生物防治杂志,1998,5(1):13-13.

同被引文献27

  • 1李青,吴雄文,熊敏,翁秀芳,卢小玲,梁智辉,龚非力.BirA酶基因表达载体的构建、原核表达及表达产物的活性鉴定[J].细胞与分子免疫学杂志,2005,21(5):557-560. 被引量:9
  • 2Yao Z, Fanslow W C, Seldin M F et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor[ J]. Immunity, 1995 ;3(6) :811-821.
  • 3Yao Z, Painter S L, Fanslow W C et al. Human IL-17: a novel cytokine derived from T cells [ J ]. J Immunol, 1995 ; 155 ( 12 ) : 5483 -5486.
  • 4Moseley T A, Haudenschild D R, Rose Let al. Interleukin-17 family and IL-17 receptors[J]. Cytokine Growth Factor Rev, 2003; 14(2) : 155-174.
  • 5Laan M, Cui Z H, Hoeshino Het al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the air ways[J] .J Immunol, 1999; 162 (4) : 2347-2352.
  • 6Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy [ J ]. Arthritis Rheum, 2003 ; 48 (3) : 594-601.
  • 7Marblestone J G, Edavettal S C, Lim Yet al. Comparison of SUMO fusion .technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO[ J ]. Protein Science, 2006; 15 : 182-189.
  • 8Bomstein P, Balian G. Cleavage at Asn-Gly bonds with hydroxylamine[ J]. Methods Enzymol, 1997 ; 47 : 132-145.
  • 9Fossiez F, Djossou O, Chomarat P et al. T cell interleukin-17 includes stromal ceils to produce proinflammatory and hematopoietic cytokines[ J]. J Exp Med, 1996; 183:259-260.
  • 10Broxmeyer H E. Is interleukin-17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules [ J ]. J Exp Med, 1996; 183 : 2411-2415.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部